Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy

Journal:

Journal of the American Chemical Society

Published:

2026-04-13

DOI:

10.1021/jacs.5c21968

Affiliations:

9

Authors:

17

Go to article

Institutions	Authors	Share
Zhejiang Cancer Hospital (ZJCH), China	7.000000	0.41
Hangzhou Institute of Medicine (HIM), CAS, China	7.000000	0.41
Karolinska Institute (KI), Sweden	1.000000	0.06
University of Macau (UM), China	0.333333	0.02
Tianjin University (TJU), China	0.333333	0.02
Krasnoyarsk State Medical University, Russia	0.333333	0.02
Aptamerlab LLC, Russia	0.333333	0.02
Krasnoyarsk Scientific Center (KSC), SB RAS, Russia	0.333333	0.02
Medical School, UCAS, China	0.333333	0.02

Interested in Oncology and Carcinogenesis?